Home
>
National Drug Code (NDC)
>
amlodipine besylate and atorvastatin calcium
amlodipine besylate and atorvastatin calcium - 54868-6335-0 - (amlodipine besylate and atorvastatin calcium)
Drug Information of amlodipine besylate and atorvastatin calcium
| Product NDC: | 54868-6335 |
| Proprietary Name: | amlodipine besylate and atorvastatin calcium |
| Non Proprietary Name: | amlodipine besylate and atorvastatin calcium |
| Active Ingredient(s): | 10; 80 mg/1; mg/1 & nbsp; amlodipine besylate and atorvastatin calcium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of amlodipine besylate and atorvastatin calcium
| Product NDC: | 54868-6335 |
| Labeler Name: | Physicians Total Care, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021540 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20120308 |
Package Information of amlodipine besylate and atorvastatin calcium
| Package NDC: | 54868-6335-0 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (54868-6335-0) |
NDC Information of amlodipine besylate and atorvastatin calcium
| NDC Code | 54868-6335-0 |
| Proprietary Name | amlodipine besylate and atorvastatin calcium |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (54868-6335-0) |
| Product NDC | 54868-6335 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | amlodipine besylate and atorvastatin calcium |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120308 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Physicians Total Care, Inc. |
| Substance Name | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
| Strength Number | 10; 80 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
